Helen L Booth
Overview
Explore the profile of Helen L Booth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chin D, Hernandez-Beeftink T, Donoghue L, Guillen-Guio B, Guillen-Uio B, Leavy O, et al.
medRxiv
. 2025 Feb;
PMID: 39974050
Background: Idiopathic pulmonary fibrosis (IPF) is a rare, incurable lung disease with a median survival of 3-5 years after diagnosis. Treatment options are limited. Genetic association studies can identify new...
2.
Thakker C, Warrell C, Barrett J, Booth H, Chiodini P, Defres S, et al.
J Infect
. 2024 Nov;
90(2):106328.
PMID: 39537036
Eosinophilia is a common finding in returning travellers, migrants and other travelling groups. In this setting, it often indicates an underlying helminth infection. Infections associated with eosinophilia are frequently either...
3.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
ERJ Open Res
. 2024 Feb;
10(1).
PMID: 38375425
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...
4.
Leavy O, Goemans A, Stockwell A, Allen R, Guillen-Guio B, Hernandez-Beeftink T, et al.
medRxiv
. 2024 Jan;
PMID: 38293162
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition that is more prevalent in males than females. The reasons for this are not fully understood, with differing environmental exposures...
5.
Chong D, Mikolasch T, Sahota J, Rebeyrol C, Garthwaite H, Booth H, et al.
Am J Physiol Lung Cell Mol Physiol
. 2023 Aug;
325(4):L487-L499.
PMID: 37643008
Transforming growth factor-β1 (TGFβ1) is the key profibrotic cytokine in idiopathic pulmonary fibrosis (IPF), but the primary source of this cytokine in this disease is unknown. Platelets have abundant stores...
6.
Guillen-Guio B, Paynton M, Allen R, Chin D, Donoghue L, Stockwell A, et al.
medRxiv
. 2023 Aug;
PMID: 37546732
Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the...
7.
Thakker C, Booth H, Lambert J, Morgan S, Checkley A
BMJ
. 2023 Feb;
380:e070295.
PMID: 36737076
No abstract available.
8.
Rangaka M, Hamada Y, Duong T, Bern H, Calvert J, Francis M, et al.
BMJ Open
. 2023 Jan;
12(9):e057717.
PMID: 36691120
Introduction: The successful scale-up of a latent tuberculosis (TB) infection testing and treatment programme is essential to achieve TB elimination. However, poor adherence compromises its therapeutic effectiveness. Novel rifapentine-based regimens...
9.
Khawaja A, Chong D, Sahota J, Mikolasch T, Pericleous C, Ripoll V, et al.
Front Immunol
. 2020 Nov;
11:2190.
PMID: 33178179
Neutrophilic inflammation correlates with mortality in fibrotic interstitial lung disease (ILD) particularly in the most severe form, idiopathic pulmonary fibrosis (IPF), although the underlying mechanisms remain unclear. Neutrophil function is...
10.
Allen R, Guillen-Guio B, Oldham J, Ma S, Dressen A, Paynton M, et al.
Am J Respir Crit Care Med
. 2019 Nov;
201(5):564-574.
PMID: 31710517
Idiopathic pulmonary fibrosis (IPF) is a complex lung disease characterized by scarring of the lung that is believed to result from an atypical response to injury of the epithelium. Genome-wide...